In the last few years, numerous studies have dealt with the hypermethylation of CpG islands in promoters that is frequently observed in cancer cell lines. Promoter hypermethylation is capable of repressing the expression of genes, a process which may contribute to carcinogenesis especially if the promoters of tumor suppressor genes are affected.
A recent study published in Human Molecular Genetics (Smiraglia et al., Hum. Mol. Genet., 2001, Vol. 10, No. 13, 1413-1419) reveals that the hypermethylation of CpG islands observed in cancer lines seems to be an intrinsic property specific of these cell lines. Using a method called restriction landmark genomic scanning to measure the extent of hypermethylation, the authors could show that cancer cell lines exhibited a significantly higher level of CpG island hypermethylation compared to the primary malignancies from which they originated. Furthermore, 70% of hypermethylated loci were found to be hypermethylated in cancer cell lines of different type. This observation reinforces the idea that hypermethylated loci may be less representative of a special tumor type than of a stage in the establishment of a tumourous phenotype.
Dominic J. Smiraglia
The Ohio State University
Division of Human Cancer Genetics
phone +1 614 292 6478
fax +1 614 688 4761
Message posted by: Ulrike Sattler
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...